Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

1.1K
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
1.1K
Dementia01:30

Dementia

676
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
676
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

818
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
818
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

345
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
345
Aging01:26

Aging

975
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
975

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Postoperative cognitive dysfunction and mortality following lung transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2017
Same author

Response to "Does Sleep Play a Role in the Relationship Among Depression, Anxiety, and Mortality in Lung Transplanted Patients?".

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016
Same author

Exploratory secondary analyses of a cognitive-behavioral intervention for knee osteoarthritis demonstrate reduction in biomarkers of adipocyte inflammation.

Osteoarthritis and cartilage·2016
Same author

Psychosocial Predictors of Mortality Following Lung Transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
Same author

Work and home stress: associations with anxiety and depression symptoms.

Occupational medicine (Oxford, England)·2015
Same author

Delirium affects length of hospital stay after lung transplantation.

Journal of critical care·2014

Related Experiment Video

Updated: Mar 25, 2026

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
06:58

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Published on: January 24, 2020

7.9K

Dietary Factors and Cognitive Decline.

P J Smith1, J A Blumenthal1

  • 1Department of Psychiatry and Behavioral Sciences at Duke University Medical Center, Durham, USA.

The Journal of Prevention of Alzheimer'S Disease
|February 23, 2016
PubMed
Summary

Preventing cognitive decline may involve lifestyle changes like diet. While specific nutrients show promise, whole dietary patterns like the Mediterranean diet need more research for dementia prevention.

Keywords:
Dietary patternscognitive functiondementianutrition

More Related Videos

Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach
10:13

Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach

Published on: February 14, 2014

14.3K
Using Retinal Imaging to Study Dementia
09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

22.4K

Related Experiment Videos

Last Updated: Mar 25, 2026

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
06:58

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Published on: January 24, 2020

7.9K
Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach
10:13

Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach

Published on: February 14, 2014

14.3K
Using Retinal Imaging to Study Dementia
09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

22.4K

Area of Science:

  • Neurology
  • Public Health
  • Nutritional Science

Background:

  • Cognitive decline and dementia pose a significant global health challenge, with projections indicating a substantial increase in cases.
  • Lifestyle factors, particularly dietary patterns, are increasingly recognized for their potential role in mitigating cognitive decline risk.
  • While individual nutrients (antioxidants, fatty acids, B vitamins) have been studied, their efficacy in preventing cognitive decline via randomized trials remains inconclusive.

Purpose of the Study:

  • To explore the role of dietary patterns in preventing cognitive decline and dementia.
  • To review the evidence for whole dietary approaches, such as the Mediterranean diet (MeDi) and Dietary Approaches to Stop Hypertension (DASH) diet, in cognitive health.
  • To identify gaps in current research regarding diet and cognitive function.

Main Methods:

  • Review of prospective epidemiological studies examining dietary components and cognitive function.
  • Analysis of randomized clinical trials investigating the impact of specific nutrients on neurocognition.
  • Evaluation of randomized trials assessing the effects of whole dietary interventions (MeDi, DASH) on cognitive outcomes.

Main Results:

  • Epidemiological studies suggest associations between certain dietary components and better cognitive functioning.
  • Randomized trials have generally not confirmed the benefits of isolated dietary components for neurocognition.
  • Preliminary results from trials on whole diets like MeDi and DASH show promise for cognitive health, but require further investigation.

Conclusions:

  • Current evidence is insufficient to recommend specific dietary components for preventing cognitive decline.
  • Whole dietary patterns, such as the Mediterranean and DASH diets, present a promising avenue for future research in dementia prevention.
  • More robust randomized controlled trials are needed to establish the efficacy of dietary interventions in maintaining cognitive health.